{
  "ptid_time": "014_S_4079_2011-09-22",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4079/2011-09-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 19,316 mm³, 13.5% below the reference mean. With a Z-score of -0.34 (36.8th percentile), this represents normal volume ; hippocampal volume measures 5,799 mm³, 24.5% below the reference mean. With a Z-score of -2.75 (0.3th percentile), this represents significant atrophy; whole brain volume measures 1,030,240 mm³, 0.1% above the reference mean. With a Z-score of 0.01 (50.5th percentile), this represents normal volume ; entorhinal cortex volume measures 2,698 mm³, 30.7% below the reference mean. With a Z-score of -2.38 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,239 mm³, 21.8% below the reference mean. With a Z-score of -2.46 (0.7th percentile), this represents significant atrophy; middle temporal gyrus volume measures 16,494 mm³, 19.6% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 64.5 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Hematopoietic-Lymphatic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 25.0. MoCA: 21.0. Logical Memory: 4.0. Laboratory findings: Serum Glucose: 153.00 (profound elevated); Total Protein: 6.20 (significant reduced); LDH: 249.00 (significant elevated); Triglycerides (GPO): 340.00 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated); Amyloid beta: 704.50 pg/mL (normal ); Total tau: 532.50 pg/mL (profound elevated); Phosphorylated tau: 50.27 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The imaging shows significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and moderate atrophy in the middle temporal gyrus—key regions affected in Alzheimer's disease. Combined with profound elevations in T-tau, P-tau, and AV45 (indicating amyloid pathology), along with borderline cognitive scores (MMSE 25, MoCA 21), this strongly suggests neurodegenerative disease. Aβ being normal is atypical but may reflect a tau-predominant or late-stage amyloid-clearing phenotype.  \n\nDiagnosis: **Dementia** (likely Alzheimer’s disease despite normal Aβ, given tau/AV45 biomarkers and structural atrophy).  \nConfidence: **High** (due to converging biomarker and volumetric evidence, though Aβ discrepancy slightly reduces certainty).",
  "timestamp": "2025-07-25T23:51:11.886870"
}